kitio.aiArteraAI vs Lunit
A side-by-side look at pricing plans, free tiers, features, pros and cons, updated for 2026. ArteraAI starts at See pricing page and Lunit starts at See pricing page. Check both pricing pages for current plans.
At a glance
Best for
Pricing model
Starting price
Free plan
Made by
Based in
Rating
Key features
- Prostate cancer risk test
- Breast cancer test
- Uses existing H&E slides
- 1-2 day turnaround
- Online ordering portal
- Mammography AI
- Chest X-ray analysis
- Pathology biomarker analysis
- Breast density assessment
- PACS integration
| Feature | ArteraAI | Lunit |
|---|---|---|
| Best for | AI pathology tests that predict cancer outcomes and therapy benefit | AI for cancer screening on mammograms and chest X-rays |
| Category | Legal, finance & HR | Legal, finance & HR |
| Pricing model | Paid | Paid |
| Starting price | See pricing page | See pricing page |
| Free plan | No | No |
| Made by | Artera | Lunit |
| Based in | United States | South Korea |
| Rating | No ratings yet | No ratings yet |
| Key features |
|
|
Pricing compared
ArteraAI starts at See pricing page and Lunit starts at See pricing page. Check both pricing pages for current plans.
Free plan
Cheapest paid plan
Top plan
Free trial
Prices in USD, checked Oct 28, 2026 or later. Plans change often, so confirm on each tool's site before you buy.
Pros and cons
ArteraAI
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
- Ordered by clinicians only
- Covers few cancer types so far
- Cost depends on insurance coverage
Lunit
- Strong breast screening results
- Regulatory clearances worldwide
- Covers imaging and pathology
- Sold to hospitals only
- Integration with PACS required
- Pricing not public
Which one should you choose?
Choose ArteraAI if you want:
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
Watch out: ordered by clinicians only.
Choose Lunit if you want:
- Strong breast screening results
- Regulatory clearances worldwide
- Covers imaging and pathology
Watch out: sold to hospitals only.
ArteraAI vs Lunit FAQ
What is the difference between ArteraAI and Lunit?
ArteraAI: AI pathology tests that predict cancer outcomes and therapy benefit. Lunit: AI for cancer screening on mammograms and chest X-rays. Both are legal, finance & hr tools.
Is ArteraAI or Lunit cheaper?
ArteraAI starts at See pricing page and Lunit starts at See pricing page. Check both pricing pages for current plans.
Do ArteraAI and Lunit have free plans?
ArteraAI: No. Lunit: No.
Who makes ArteraAI?
ArteraAI is made by Artera, based in United States.
Who makes Lunit?
Lunit is made by Lunit, based in South Korea.
Which should I choose, ArteraAI or Lunit?
Choose ArteraAI if you value fda de novo authorization and listed in nccn prostate guidelines. Choose Lunit if you value strong breast screening results and regulatory clearances worldwide.